London Business School announces £25 million gift from the David and Molly Pyott Foundation and David and Molly Pyott

1 hour ago 3

Article content

The School equips its diverse student body with the tools needed to tackle today’s business challenges and connects them with many of the world’s leading thinkers. Its global community includes more than 58,000 alumni working in over 160 countries, united by a wealth of knowledge, experience and worldwide networking opportunities. London Business School’s faculty members come from more than 30 countries and cover seven core subject areas, including accounting, economics, finance, management science and operations, marketing, organisational behaviour, and strategy and entrepreneurship.

Article content

For more information, visit www.london.edu

Article content

About the David and Molly Pyott Foundation

Article content

Led by President Dr David E.I. Pyott, CBE, CStJ and Vice President Molly Pyott, the David and Molly Pyott Foundation supports initiatives focused on education, healthcare and opportunity, including programmes that educate ophthalmologists worldwide, help young people access employment opportunities, improve support for people with disabilities, and advance the performing arts.

Article content

Article content

About David Pyott

Article content

Dr. David E.I. Pyott, CBE, CStJ is Chair of London Business School’s Governing Body.

Article content

Dr. Pyott has a longstanding relationship with the School. An LBS alumnus, MSc13 (1980), he became a Fellow of London Business School in 2006. In the same year, Dr. Pyott received a CBE for services to British business excellence and management skills in the United States. A member of the Governing Body since 2015, Deputy Chair since 2018, and Chair since 2023, Dr. Pyott passionately believes in the vibrancy of the School’s multinational community of faculty, students, alumni, and staff. He will build on the School’s leading position in Executive Education and contribute to the School’s ambition to have a profound impact on the way the world does business and the way business impacts the world.

Article content

Dr. Pyott is a member of the Board of Alnylam Pharmaceuticals and Tarsus Pharmaceuticals. Formerly, he was a member of the Supervisory Board of Royal Philips and a Director of BioMarin Pharmaceutical. In addition, he is a trustee and member of the Executive Committee of the California Institute of Technology. He was promoted in 2023 to Commander of the Order of St. John.

Article content

Article content

Dr. Pyott is a board director for many not-for-profit organisations across America, Europe, and Africa. He and his wife, Molly, created the David & Molly Pyott Foundation, which educates ophthalmologists worldwide, supports young people in employment, improves care for disabled individuals, and advances the performing arts.

Article content

About Molly Pyott

Article content

Molly Pyott serves as Vice President of the David and Molly Pyott Foundation a private charity registered in Colorado which is focused on philanthropy in a few areas: improving care for disabled individuals; enabling disadvantaged youth secure employment; teaching and educating ophthalmologists in lower and middle income countries; and advancing the performing arts. Ms Pyott leads development and operational strategy for significant grants to The King’s Trust (formerly the Prince’s Trust) founded by King Charles III; ORBIS International, a global eyecare charity addressing preventable blindness in lower- and middle-income countries; the Ophthalmology Foundation, a U.S.-based charity that creates programs to enhance the skills of ophthalmic educators worldwide; and to classical music and the performing arts. Previously, she was Chairwoman of Easterseals Southern California, a U.S.-based charity providing life-changing services to people with disabilities. She is an Officer in the Order of St. John.

Article content

For more information, contact

Article content

Christopher Moseley,

Article content

Senior PR Manager

Article content

London Business School         

Article content

Email [email protected]

Article content

Mobile +44 7511 577803

Article content

Article content

Article content

Article content

Article content

Article content

Article content

Article content

Read Entire Article